                         SEQUENCE LISTING

<110>  Rheinisch-Westfaelische Technische Hochschule (RWTH) Aachen
 
<120>  Kardioprotektiver Effekt des Vasokonstriktion-inhibierenden 
       Faktors (VIF)

<130>  RM 5194-02WO

<150>  DE102019102786.1
<151>  2019-02-05

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  35
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ser Gly Phe Glu Asp Glu Leu Ser Glu Val Leu Glu Asn Gln Ser 
1               5                   10                  15      


Ser Gln Ala Glu Leu Lys Glu Ala Val Glu Glu Pro Ser Ser Lys Asp 
            20                  25                  30          


Val Met Glu 
        35  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  2

Glu Asp Glu Leu Ser Glu Val Leu Glu 
1               5                   


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  3

Lys Glu Ala Val Glu Glu Pro 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  4

Ser Ser Lys Asp Val Met Glu 
1               5           


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  5

His Ser Gly Phe Glu Asp Glu Leu 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  6

Pro Ser Ser Lys Asp Val Met Glu 
1               5               


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  7

Asn Gln Ser Ser Gln Ala Glu Leu Lys Glu Ala Val Glu Glu Pro 
1               5                   10                  15  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  8

Lys Glu Ala Val Glu Glu Pro Ser Ser Lys Asp Val Met Glu 
1               5                   10                  


